INHIBIKASE THERAPEUTICS INC

CUSIP: 45719W106 Class: COM

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 39,007 Value ($000) $26 Avg Close Range
Q4 2022
Shares 39,007 Value ($000) $20 Avg Close Range
Q3 2022
Shares 39,312 Value ($000) $36 Avg Close Range
Q2 2022
Shares 39,312 Value ($000) $29 Avg Close Range
Q1 2022
Shares 39,580 Value ($000) $59 Avg Close Range
Q4 2021
Shares 39,580 Value ($000) $58 Avg Close Range
Q3 2021
Shares 39,580 Value ($000) $75 Avg Close Range